NAL ER IPF Respiratory Function and Safety Study

Recruiting

Phase 1

NAL ERNAL ER IPF Respiratory Function and Safety Study

Sponsor:

Trevi Therapeutics

Code:

NCT07036029

Conditions

Idiopathic Pulmonary Fibrosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NAL ER

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-01-23. This information was provided to ClinicalTrials.gov by Trevi Therapeutics on 2026-01-21.